Immunology Research
Click the below button to learn more about our autoimmune disease research and clinical trials.
Learn MoreThe main purpose of this study is to evaluate the efficacy and safety of LY3857210 in participants with osteoarthritic pain. This trial is part of the chronic pain master protocol (H0P-MC-CPMP) which is a protocol to accelerate the development of new treatments for chronic pain.
Have a history of daily pain for at least 12 weeks
Participants must be willing to maintain any non-drug pain relieving therapies (for example, physical therapy) and not start any new non-drug pain-relieving therapies during the study
Are willing to discontinue all medications taken for chronic pain conditions throughout the study
Have knew pain for >12 weeks at screening
Have a siezure disorder or history of seizure
Have had a surgical procedure or therapeutic injection in the affected knee within 3 months prior to starting the washout period
Have presence of surgical hardware or other foreign body in the index knee.
Have a surgery planned during the study for any reason
Have had cancer within 2 years of baseline
Click the below button to learn more about our autoimmune disease research and clinical trials.
Learn MoreFor the past 20 years, Lilly has worked to develop treatments for people living with chronic or regular pain. Click the below button to learn more about pain research and clinical trials.
Learn MoreA clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.